Pulse Biosciences, Inc. PLSE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Pulse Biosciences, Inc. is a bioelectric medicine company specializing in the development of novel Nanosecond Pulsed Field Ablation (nsPFA) platforms. Its primary focus centers on the patented nPulse technology, which enables precise, non-thermal ablation of soft tissues for applications in dermatology, cardiology, and…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Instruments & Supplies
CountryUnited States
Employees116
TickerPLSE
Statistics
Market Cap$1.71B
Revenue (TTM)$350000
Net Income-$72.8M
Net Margin-20794.6%
EPS—
P/E-25.10
P/S2478.09
P/B27.66
EV/EBITDA-21.84
ROE-80.7%
Dividend Yield—
Price$25.09
Data: Twelve Data · Revenue = mcap / P/S